BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29708428)

  • 1. Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.
    Funkhouser WK; Hayes DN; Moore DT; Funkhouser WK; Fine JP; Jo H; Nikolaishvilli-Feinberg N; Eeva M; Grilley-Olson JE; Banks PM; Graziano P; Boswell EL; Elmberger G; Raparia K; Hart CF; Sholl LM; Nolan NJ; Fritchie KJ; Pouagare E; Allen TC; Volmar KE; Biddinger PW; Kleven DT; Papez MJ; Spencer DV; Rekhtman N; Mino-Kenudson M; Hariri L; Driver B; Cagle PT
    Arch Pathol Lab Med; 2018 Dec; 142(12):1537-1548. PubMed ID: 29708428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets.
    Grilley-Olson JE; Hayes DN; Moore DT; Leslie KO; Wilkerson MD; Qaqish BF; Hayward MC; Cabanski CR; Yin X; Socinski MA; Stinchcombe TE; Thorne LB; Allen TC; Banks PM; Beasley MB; Borczuk AC; Cagle PT; Christensen R; Colby TV; Deblois GG; Elmberger G; Graziano P; Hart CF; Jones KD; Maia DM; Miller CR; Nance KV; Travis WD; Funkhouser WK
    Arch Pathol Lab Med; 2013 Jan; 137(1):32-40. PubMed ID: 22583114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
    Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
    J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines.
    Ericson Lindquist K; Ciornei C; Westbom-Fremer S; Gudinaviciene I; Ehinger A; Mylona N; Urdar R; Lianou M; Svensson F; Seidal T; Haglund F; Dobra K; Béndek M; Bardóczi E; Szablewska A; Witkowski M; Ramnefjell M; De Las Casas LE; Gulyas M; Hegedus A; Micke P; Brunnström H
    J Clin Pathol; 2022 May; 75(5):302-309. PubMed ID: 33547095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA.
    Steinfort DP; Russell PA; Tsui A; White G; Wright G; Irving LB
    Eur Respir J; 2012 Sep; 40(3):699-705. PubMed ID: 22323573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry in the workup of prostate biopsies: Frequency, variation and appropriateness of use among pathologists practicing at an academic center.
    Al Diffalha S; Shaar M; Barkan GA; Wojcik EM; Picken MM; Pambuccian SE
    Ann Diagn Pathol; 2017 Apr; 27():34-42. PubMed ID: 28325359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
    Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
    J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of subtypes including LCNEC in lung cancer biopsy slides using convolutional neural network from scratch.
    Yang JW; Song DH; An HJ; Seo SB
    Sci Rep; 2022 Feb; 12(1):1830. PubMed ID: 35115593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens.
    Sigel CS; Moreira AL; Travis WD; Zakowski MF; Thornton RH; Riely GJ; Rekhtman N
    J Thorac Oncol; 2011 Nov; 6(11):1849-56. PubMed ID: 21841504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchial biopsies--in praise of an H&E section.
    Pandit D; Griffiths D; Edwards J
    Histopathology; 2006 Jul; 49(1):96-7. PubMed ID: 16842256
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.
    Micke P; Botling J; Mattsson JSM; Planck M; Tran L; Vidarsdottir H; Nodin B; Jirström K; Brunnström H
    Sci Rep; 2019 Feb; 9(1):1319. PubMed ID: 30718697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretive disparity among pathologists in breast sentinel lymph node evaluation.
    Roberts CA; Beitsch PD; Litz CE; Hilton DS; Ewing GE; Clifford E; Taylor W; Hapke MR; Babaian A; Khalid I; Hall JD; Lindberg G; Molberg K; Saboorian H
    Am J Surg; 2003 Oct; 186(4):324-9. PubMed ID: 14553843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
    da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
    Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid on-site evaluation has high diagnostic yield differentiating adenocarcinoma vs squamous cell carcinoma of non-small cell lung carcinoma, not otherwise specified subgroup.
    Celik B; Khoor A; Bulut T; Nassar A
    Pathol Oncol Res; 2015 Jan; 21(1):167-72. PubMed ID: 24889857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Analysis for Diagnostic Yield of Small Cell Lung Cancer by Cytology and Histology During the Same Bronchoscopic Procedure.
    Li WN; Wang DF; Zhao YB; Qiu XS; Wang EH; Wu GP
    Clin Lung Cancer; 2017 Sep; 18(5):e357-e361. PubMed ID: 28342728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.
    Zachara-Szczakowski S; Verdun T; Churg A
    Hum Pathol; 2015 May; 46(5):776-82. PubMed ID: 25776027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance validation in anatomic pathology: successful integration of a new classification system into the practice setting using the updated lung non-small cell carcinoma recommendations.
    Murugan P; Stevenson ME; Hassell LA
    Arch Pathol Lab Med; 2014 Jan; 138(1):105-9. PubMed ID: 24377817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of immunohistochemical stain usage in different pathology practice settings.
    Shah AA; Frierson HF; Cathro HP
    Am J Clin Pathol; 2012 Dec; 138(6):831-6. PubMed ID: 23161717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
    Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
    J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.